Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 7th Glioblastoma Drug Development Summit.

Do-Hyun Nam, speaking at 7th Glioblastoma Drug Development Summit

Do-Hyun Nam

Founder & Chief executive Officer
Aimed Bio Inc.
Mykola Zdioruk, speaking at the 7th Glioblastoma Drug Development Summit

Mykola Zdioruk

Senior Scientist
AstraZeneca

Kirk Tanner

SVP Clinical Development
Autem Therapeutics
John Higgins, speaking at the 7th Glioblastoma Drug Development Summit

John Higgins

Managing Director
Brain Tumor Investment Fund
Francesca Barone, speaking at 7th Glioblastoma Drug Development Summit

Francesca Barone

CSO
Candel Therapeutics
Saskia Biskup, speaking at the 7th Glioblastoma Drug Development Summit

Saskia Biskup

Managing Director
CeGaT GmbH

Michael Boice, PhD

Senior Director, Scientific Engagement and Key Accounts
Certis Oncology Solution
Sandra Silberman, speaking at the 7th Glioblastoma Drug Development Summit

Sandra Silberman

CMO
CNS Pharmaceuticals
Liisi Laaniste, speaking at the 7th Glioblastoma Drug Development Summit

Liisi Laaniste

Chief Scientific Officer and Co-Founder
CoSyne Therapeutics
Ulrike Gerdermann, speaking at the 7th Glioblastoma Drug Development Summit

Ulrike Gerdemann

Assistant professor
Dana-Farber Cancer Institute
Sam Blackman, speaking at the 7th Glioblastoma Drug Development Summit

Sam Blackman

EIR
Google Ventures
Jianping Huang, speaking at the 7th Glioblastoma Drug Development Summit

Jianping Huang

CEO
Immunogenik
Aaron Edwards, speaking at 7th Glioblastoma Drug Development Summit

Aaron Edwards

Co-Founder & Chief Executive Officer
KiraGen Bio
Victoria Llado Canellas, speaking at the 7th Glioblastoma Drug Development Summit

Victoria Llado

CSO
Laminar Pharma Inc
Panna Sharma, speaking at the 7th Glioblastoma Drug Development Summit

Panna Sharma

Chief Executive Officer, President & Board Member
Lantern Pharma
Fahar Merchant, speaking at the 7th Glioblastoma Drug Development Summit

Fahar Merchant

President and CEO
Medicenna Therapeutics

William Gwynne


Carla bauer, speaking at 7th Glioblastoma Drug Development Summit

Carla Bauer

Director, Search & Evaluation, Business Development & Licensing
Merck & Co
Jason Binder, speaking at the 7th Glioblastoma Drug Development Summit

Jason Binder

Head of Patient Experience
Pathos AI

Sandeep Kunwar, MD

CEO
Precision NeuroMed
Jonathan Pritz, speaking at the 7th Glioblastoma Drug Development Summit

Jonathan Pritz

Investment Director
RA Capital Management

Rashida Karmali

CEO
Tactical Therapeutics
Daniel yokell, speaking at 7th Glioblastoma Drug Development Summit

Daniel Yokell

VP Neuro
Telix Pharmaceuticals
David Tran, speaking at 7th Glioblastoma Drug Development Summit

David Tran

Director
University of Southern California
David Anderson, speaking at 7th Glioblastoma Drug Development Summit

David Anderson

Chief Scientific Officer
VBI Vaccines & HDT Bio

Eric Fossel

Chief Executive Officer
Viska Bio
Yash Thukral, speaking at the 7th Glioblastoma Drug Development Summit

Yash Thukral

Executive Director
White Lion Capital LLC
Ranjit Bindra, speaking at the 7th Glioblastoma Drug Development Summit

Ranjit bindra

professor
Yale Univerisity
7th Glioblastoma Drug Development Summit - Conference Image
Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

View Presentations & Speakers
7th Glioblastoma Drug Development Summit - Conference Image
Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Explore Sponsorship Options
7th Glioblastoma Drug Development Summit - Conference Image
Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.

Register Now